Envoy Medical (COCH) Preferred Stock Liabilities (2021 - 2026)

Envoy Medical has disclosed Preferred Stock Liabilities across 5 years of filings, most recently posting $391000.0 for Q1 2026.

• Preferred Stock Liabilities for Q1 2026 came in at $391000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $391000.0 (changed N/A YoY), and the FY2025 annual result was $391000.0, changed N/A from the prior year.
• Preferred Stock Liabilities came in at $391000.0 for Q1 2026 at Envoy Medical, roughly flat from $391000.0 in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $429.7 million in Q4 2022 to a low of $130000.0 in Q3 2025.
• The 4-year median for Preferred Stock Liabilities is $44.6 million (2023), against an average of $199.6 million.
• Across the five-year window, Preferred Stock Liabilities advanced 1.19% in 2022 and sank 89.61% in 2023, its largest moves.
• Envoy Medical's Preferred Stock Liabilities stood at $429.7 million in 2022, then plunged by 89.62% to $44.6 million in 2023, then sank by 99.12% to $391000.0 in 2025, then changed by 0.0% to $391000.0 in 2026.
• The last three Preferred Stock Liabilities figures came in at $391000.0 (Q1 2026), $391000.0 (Q4 2025), and $130000.0 (Q3 2025), per Business Quant data.